中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共4条，第1-4条 帮助

条数/页： 排序方式：
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文  OAI收割
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
  |  收藏  |  浏览/下载：51/0  |  提交时间：2022/05/05
A phase 2 study of tislelizumab monotherapy in patients with previously treated, locally advanced unresectable ormetastatic microsatellite instability-high/mismatch repair deficient solid tumors. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jian;  Xu, Ye;  Zang, Aimin;  Gao, Yunong;  Gao, Quanli
  |  收藏  |  浏览/下载：53/0  |  提交时间：2022/01/10
Tislelizumab (BGB-A317) for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL): Long-term follow-up efficacy and safety results from a phase 2 study. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
  |  收藏  |  浏览/下载：53/0  |  提交时间：2022/01/10
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma 期刊论文  OAI收割
NATURE, 2019, 卷号: 567, 期号: 7747, 页码: 257-+
作者:  Jiang, Ying;  Sun, Aihua;  Zhao, Yang;  Ying, Wantao;  Sun, Huichuan
  |  收藏  |  浏览/下载：62/0  |  提交时间：2020/07/01